Dr. Lee Jong-wook's Key Research Areas and Achievements
Dr. Lee Jong-wook led the World Health Organization (WHO) as Director-General, established the 'Lee Jong-wook Fellowship' program to train infectious disease specialists, and was awarded an honorary Doctor of Medicine degree by Seoul National University. He also founded the 'Lee Jong-wook Public Health Award,' which will recognize experts in infectious diseases starting in 2026. As Chairman of the Association of Korean Scientists and Engineers in France (ASCoF), he contributed to building a Korea-Europe technology alliance in AI and aerospace fields. Additionally, through collaboration with GC Green Cross Medical Foundation and KOFIH, he advanced healthcare talent development programs for developing countries. Dr. Lee also served as President of the Korean Society of Clinical Microbiology and as a professor at Catholic University of Korea's Department of Internal Medicine. His work on leprosy relief efforts gained renewed recognition, and in 2023, as former CEO of Daewoong Pharmaceutical, he founded the biotech venture 'Nawi'.
Dr. Lee Jong-wook's WHO Leadership and Contributions to Infectious Disease
As WHO Director-General, Dr. Lee played a pivotal role in international cooperation on infectious disease response. He led the 'Lee Jong-wook Fellowship,' an initiative aimed at training healthcare professionals from developing countries. The program, developed with GC Green Cross Medical Foundation and KOFIH, held its inaugural ceremony on July 26, 2023, followed by a guest lecture series concluding on October 29, 2025. A field education session is scheduled for September 1–2, 2026.
Seoul National University awarded Dr. Lee an honorary Doctor of Medicine degree on September 10, 2020, recognizing his global contributions to healthcare and public health. The 'Lee Jong-wook Public Health Award' will announce its first recipients on May 21, 2026.

Building Technology Alliances as ASCoF Chairman
As Chairman of the Association of Korean Scientists and Engineers in France (ASCoF), Dr. Lee spearheaded efforts to establish a Korea-Europe technology alliance platform in AI and aerospace fields. On June 9, 2025, he presented related initiatives at EKC-2026, with coverage highlighting ASCoF's activities. His work has strengthened international collaboration to drive technological advancement and innovation in healthcare.
The Seoul National University Lee Jong-wook Global Medicine Center recently concluded a medical training program for cardiologists from Kyrgyzstan on November 24, 2025, enhancing healthcare capacity in developing nations. This project serves as an extension of the 'Lee Jong-wook Fellowship' initiative.
Founding Biotech Venture 'Nawi' as Former Daewoong CEO
On July 26, 2023, Dr. Lee founded the biotech venture 'Nawi' as former CEO of Daewoong Pharmaceutical. The company represents a new model for collaboration between medical research and industry, focusing on infectious disease drug development. Nawi aims to improve efficiency in pharmaceutical R&D through active market engagement.
Dr. Lee has served as President of the Korean Society of Clinical Microbiology and as a professor at Catholic University of Korea's Department of Internal Medicine. In 2016, he organized a memorial service for his 10th anniversary at the WHO General Assembly, highlighting his dedication to healthcare. His volunteer work in leprosy relief has also been widely recognized.
Operational Details of the Lee Jong-wook Fellowship Program
The 'Lee Jong-wook Fellowship' program for infectious disease specialists is conducted jointly by GC Green Cross Medical Foundation and KOFIH. The guest lecture series concluded on October 29, 2025, with a field consultation scheduled for February 6, 2026. The program aims to train healthcare professionals from developing countries such as nurses. Starting with the July 26, 2023, induction ceremony, field education and site visits are planned for September 1–2, 2026.
The Seoul National University Lee Jong-wook Global Medicine Center plans to participate in the International Association of Schools of Public Health 2026, seeking broader international collaboration. The center honors Dr. Lee's legacy while contributing to global healthcare development.
Key Achievements and Contributions
Dr. Lee made significant contributions across multiple fields as WHO Director-General, including strengthening international infectious disease cooperation, establishing the 'Lee Jong-wook Fellowship' for expert training, receiving an honorary Doctor of Medicine from Seoul National University, and founding the 'Lee Jong-wook Public Health Award.' As Chairman of ASCoF, he contributed to building a Korea-Europe technology alliance in AI and aerospace. Through collaboration with GC Green Cross Medical Foundation and KOFIH, he led initiatives for healthcare talent development in developing countries.
As former CEO of Daewoong Pharmaceutical, founding 'Nawi' represents a new approach to strengthening medical research-industry collaboration. His leadership as President of the Korean Society of Clinical Microbiology and professor at Catholic University of Korea further demonstrated his expertise and leadership in healthcare.
10th Anniversary Memorial Service and Leprosy Volunteer Work
A memorial service for Dr. Lee's 10th anniversary was held at the WHO General Assembly on May 25, 2016, honoring his contributions to global health. This event reflected his deep commitment to healthcare.
Dr. Lee gained renewed recognition for his volunteer work in leprosy relief, which is viewed as a direct example of how he contributed to improving people's lives through practical healthcare initiatives. Leprosy remains a significant health issue worldwide, and his efforts exemplify his life philosophy and passion for public health.
International Expansion of the Lee Jong-wook Fellowship Program
The 'Lee Jong-wook Fellowship' program aims to train healthcare professionals from developing countries in infectious disease response. The guest lecture series concluded on October 29, 2025, with a field consultation scheduled for February 6, 2026. This initiative is contributing to strengthening infectious disease response capabilities in developing nations.
The Seoul National University Lee Jong-wook Global Medicine Center plans to participate in the International Association of Schools of Public Health 2026 to explore broader international collaboration. The center honors Dr. Lee's legacy while advancing global healthcare development.
Founding Biotech Venture 'Nawi'
As former CEO of Daewoong Pharmaceutical, Dr. Lee established the biotech venture 'Nawi' on July 26, 2023. The company focuses on infectious disease drug development and represents a new model for medical research-industry collaboration. Nawi aims to enhance efficiency in pharmaceutical R&D through proactive market engagement.
Building on his expertise and experience in infectious diseases, Dr. Lee has directed 'Nawi' toward developing technologies and treatments for infectious diseases. This approach aligns with his WHO Director-General experience and aims to strengthen international cooperation for more effective global infectious disease response systems.
Information to Verify
The key dates for the 'Lee Jong-wook Fellowship' program include: July 26, 2023 (induction ceremony), October 29, 2025 (guest lecture series completion), February 6, 2026 (field consultation), and September 1–2, 2026 (field education and site visits). The program targets training healthcare professionals from developing countries such as nurses.
The Seoul National University Lee Jong-wook Global Medicine Center will participate in the International Association of Schools of Public Health 2026. The 'Lee Jong-wook Public Health Award' is scheduled to announce its first winners on May 21, 2026, marking a significant event honoring Dr. Lee's legacy.
Frequently Asked Questions
What is the purpose of the Lee Jong-wook Fellowship program?
The 'Lee Jong-wook Fellowship' for infectious disease specialists aims to train healthcare professionals from developing countries through collaboration between GC Green Cross Medical Foundation and KOFIH.
What were Dr. Lee's contributions as WHO Director-General?
Dr. Lee led international cooperation on infectious disease response, established the 'Lee Jong-wook Fellowship' for training specialists, and contributed to global health initiatives.
What is the main goal of biotech venture 'Nawi'?
'Nawi' focuses on developing new drugs and treatments for infectious diseases while strengthening collaboration between medical research and industry.
Frequently Asked Questions
Dr. Lee Jong-wook's key achievements include: leading WHO in international infectious disease cooperation, establishing the 'Lee Jong-wook Fellowship' program, receiving an honorary Doctor of Medicine from Seoul National University, founding the 'Lee Jong-wook Public Health Award,' contributing to Korea-Europe technology alliances as ASCoF Chairman, and advancing healthcare talent development for developing countries through GC Green Cross Medical Foundation and KOFIH. As President of the Korean Society of Clinical Microbiology and a professor at Catholic University of Korea's Department of Internal Medicine, he demonstrated expertise in healthcare. In 2023, as former CEO of Daewoong Pharmaceutical, he founded 'Nawi,' establishing a new model for medical research-industry collaboration. Dr. Lee's legacy contributes to international cooperation and support for developing nations in the healthcare sector.
You can view similar articles all at once.
View More ArticlesFAQ
What is the purpose of the Lee Jong-wook Fellowship program?
The 'Lee Jong-wook Fellowship' for infectious disease specialists aims to train healthcare professionals from developing countries through collaboration between GC Green Cross Medical Foundation and KOFIH.
What were Dr. Lee's contributions as WHO Director-General?
Dr. Lee led international cooperation on infectious disease response, established the 'Lee Jong-wook Fellowship' for training specialists, and contributed to global health initiatives.
What is the main goal of biotech venture 'Nawi'?
'Nawi' focuses on developing new drugs and treatments for infectious diseases while strengthening collaboration between medical research and industry.
Korean Source
This article is an English localization of a Korean-language report from BlogScore. Original: 이종욱박사의 주요 연구 분야와 성과 정리